<h2 id="mechanism-of-action-">Mechanism of Action <sup id="fnref:1" role="doc-noteref"><a href="#fn:1" class="footnote" rel="footnote">1</a></sup><sup id="fnref:2" role="doc-noteref"><a href="#fn:2" class="footnote" rel="footnote">2</a></sup></h2>
<ul>
  <li>Ondansetron is a selective <strong>5-HT₃ receptor antagonist</strong> that blocks serotonin receptors in the <strong>chemoreceptor trigger zone (CTZ)</strong>, preventing the initiation of the vomiting reflex.</li>
</ul>
<h2 id="indications-">Indications <sup id="fnref:1:1" role="doc-noteref"><a href="#fn:1" class="footnote" rel="footnote">1</a></sup><sup id="fnref:2:1" role="doc-noteref"><a href="#fn:2" class="footnote" rel="footnote">2</a></sup></h2>
<ul>
  <li>Prophylaxis and treatment of <strong>postoperative nausea and vomiting (PONV)</strong>.</li>
</ul>
<h2 id="dosage-">Dosage <sup id="fnref:1:2" role="doc-noteref"><a href="#fn:1" class="footnote" rel="footnote">1</a></sup><sup id="fnref:3" role="doc-noteref"><a href="#fn:3" class="footnote" rel="footnote">3</a></sup></h2>
<ul>
  <li><strong>Postoperative Nausea and Vomiting (PONV) Prophylaxis:</strong>
    <ul>
      <li><strong>Adults:</strong> 4 mg IV over 2-5 minutes at the end of surgery.</li>
      <li><strong>Children:</strong> 0.1 mg/kg IV (up to 4 mg) at the end of surgery.</li>
    </ul>
  </li>
  <li><strong>Oral:</strong> 8 mg orally, 1 hour before anesthesia or chemotherapy (50% bioavailability).</li>
</ul>
<h2 id="complications-">Complications <sup id="fnref:1:3" role="doc-noteref"><a href="#fn:1" class="footnote" rel="footnote">1</a></sup><sup id="fnref:2:2" role="doc-noteref"><a href="#fn:2" class="footnote" rel="footnote">2</a></sup></h2>
<ul>
  <li><strong>Headache:</strong> Common, with a number needed to harm (NNH) of 36.</li>
  <li><strong>QTc Prolongation:</strong> May prolong the QT interval</li>
  <li><strong>Constipation:</strong> NNH of 23.</li>
  <li><strong>Elevated Liver Enzymes:</strong> NNH of 31, though often transient and clinically insignificant.</li>
</ul>
<h2 id="pharmacokinetics-">Pharmacokinetics <sup id="fnref:2:3" role="doc-noteref"><a href="#fn:2" class="footnote" rel="footnote">2</a></sup></h2>
<ul>
  <li><strong>Onset of Action:</strong> 30 to 60 minutes after oral or IV administration.</li>
  <li><strong>Metabolism:</strong> Hepatic</li>
  <li><strong>Elimination Half-life:</strong> 3 to 4 hours.</li>
  <li><strong>Excretion:</strong> Primarily through urine as metabolites.</li>
</ul>
<h2 id="references">References</h2>
<div class="footnotes" role="doc-endnotes">
  <ol>
    <li id="fn:1" role="doc-endnote">
      <p>Gan, T.J., Belani, K.G., Bergese, S., et al. (2020). Fourth Consensus Guidelines for the Management of Postoperative Nausea and Vomiting. Anesth Analg. <a href="#fnref:1" class="reversefootnote" role="doc-backlink">&#8617;</a> <a href="#fnref:1:1" class="reversefootnote" role="doc-backlink">&#8617;<sup>2</sup></a> <a href="#fnref:1:2" class="reversefootnote" role="doc-backlink">&#8617;<sup>3</sup></a> <a href="#fnref:1:3" class="reversefootnote" role="doc-backlink">&#8617;<sup>4</sup></a></p>
    </li>
    <li id="fn:2" role="doc-endnote">
      <p>Shafer SL, Rathmell JP, Flood P. <em>Stoelting’s Pharmacology and Physiology in Anesthetic Practice.</em> Fifth edition. Philadelphia: Wolters Kluwer Health, 2015. <a href="#fnref:2" class="reversefootnote" role="doc-backlink">&#8617;</a> <a href="#fnref:2:1" class="reversefootnote" role="doc-backlink">&#8617;<sup>2</sup></a> <a href="#fnref:2:2" class="reversefootnote" role="doc-backlink">&#8617;<sup>3</sup></a> <a href="#fnref:2:3" class="reversefootnote" role="doc-backlink">&#8617;<sup>4</sup></a></p>
    </li>
    <li id="fn:3" role="doc-endnote">
      <p>Coté CJ, Lerman J, Anderson BJ. <em>A Practice of Anesthesia for Infants and Children.</em> Seventh edition. Philadelphia, PA: Elsevier, 2024. <a href="#fnref:3" class="reversefootnote" role="doc-backlink">&#8617;</a></p>
    </li>
  </ol>
</div>